✦ LIBER ✦

Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients

✍ Scribed by A. Lehtonen

Publisher: Springer US
Year: 1988
Tongue: English
Weight: 320 KB
Volume: 1
Category: Article
ISSN: 0920-3206
DOI: 10.1007/bf02125739

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long term treatment with tienilic acid o

Long term treatment with tienilic acid or thiazides: Comparison of antihypertensive and metabolic effects

✍ L. A. Ferrara; A. Siani; P. Strazzullo; F. Galletti 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 306 KB

The effect of long-term treatment with s

The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites

✍ F Nevens; P Lijnen; H VanBilloen; J Fevery 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

Effects of short- and long-term administ

Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension

✍ Jun Sasaki; Kikuo Arakawa 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 235 KB

The effect of nisoldipine on renal funct

The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment

✍ J. Wilson; M. M. A. E. Wahbha; P. G. Martin; R. Hainsworth; A. M. Brownjohn; J. 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 612 KB

The metabolism of cyclophosphamide. Dose

The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide

✍ H. T. Mouridsen; O. Faber; L. Skovsted 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements